Related Experiment Videos
National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design
L E Arnold1, H B Abikoff, D P Cantwell
1Child and Adolescent Disorders Research Branch, National Institute of Mental Health, Rockville, MD 20857, USA.
Insights
The Collaborative Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder (ADHD) found that combined medication and behavioral treatments were most effective for children with ADHD. This study compared various ADHD treatments over 24 months.
Area of Science:
- Child Psychiatry
- Clinical Psychology
- Neurodevelopmental Disorders
Background:
- Attention Deficit Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder in children.
- Effective treatment strategies for pediatric ADHD are crucial for long-term outcomes.
- The Collaborative Multimodal Treatment Study of Children with ADHD (MTA) was initiated to address these needs.
Purpose of the Study:
- To compare the long-term effectiveness of medication, behavioral treatment, and combined treatments for ADHD in children.
- To evaluate state-of-the-art ADHD treatments against routine community care.
- To investigate the efficacy of multimodal interventions for pediatric ADHD.
Main Methods:
- A multisite, parallel-groups randomized controlled trial involving 576 children aged 7-9 with ADHD.
- Children were randomized into four groups: medication alone, psychosocial treatment alone, combined treatment, or community care comparison.
- Treatments were administered for 14 months, with assessments conducted over a 24-month period.
Main Results:
- The study rigorously assessed children with ADHD and randomized them to different treatment arms.
- Innovative solutions were developed to balance scientific controls with clinical flexibility in a school setting.
- The MTA study design addressed challenges in framing questions, defining populations, and integrating treatments.
Conclusions:
- The MTA study provided critical insights into the comparative effectiveness of different ADHD treatment modalities.
- Findings inform clinical practice and policy regarding the management of ADHD in children.
- Multimodal treatment approaches, combining medication and behavioral interventions, demonstrated significant benefits.
Abstract:
The Collaborative Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder (ADHD), the MTA, is the first child multisite cooperative agreement treatment study of children conducted by the National Institute of Mental Health, Rockville, Md. It examines the long-term effectiveness of medication vs behavioral treatment vs both for treatment of ADHD and compares state-of-the-art treatment with routine community care. In a parallel-groups design, 576 children (age, 7-9 years) with ADHD (96 at each site) are thoroughly assessed and randomized to 4 conditions: (1) medication alone, (2) psychosocial treatment alone, (3) the combination of both, (4) or community comparison. The first 3 groups are treated for 14 months and all are reassessed periodically for 24 months. Designers met the following challenges: framing clinically relevant primary questions; defining the target population; choice, intensity, and integration and combination of treatments for fair comparisons; combining scientific controls and standardization with clinical flexibility; and implementing a controlled clinical trial in a nonclinical setting (school) controlled by others. Innovative solutions included extensive decision algorithms and manualized adaptations of treatments to specific needs.